Opens in a new tab

Infographic

Navigating the Regulatory Crossroads of Drug, Device, and Biologic

Download PDF
Navigating the Regulatory Crossroads of Drug, Device, and Biologic, Syner-G

What Is a Combination Product?

As innovation merges drugs, biologics, and devices into single therapies, traditional regulatory boundaries continue to blur. While combination products improve patient convenience—such as enabling at-home self-administration—they also introduce greater regulatory complexity because each constituent part retains its individual regulatory status after combination.

The Three Types of Combination Products

  • Single-Entity Combination Products – Two or more regulated components are physically, chemically, or otherwise combined and produced as one unit.
  • Co-Packaged Combination Products – Two or more separate products packaged together in a single package or sold as a unit.
  • Cross-Labeled Combination Products – A drug, device, or biologic packaged separately but intended for use only with another specifically identified product.

Download PDF to Learn More

Related Resources

All Resources

Let's move from science to success.

Let’s Talk